Abstract |
A water-soluble polysaccharide named CYP-1 was isolated from Chinese yam. CYP-1 was characterized as a mannoglucan having a backbone consisting predominately of 1,4-α-linked Glcp branched at O-2, O-3, and O-6 position by t-α-linked Manp with a molecular weight of 2.86 kDa. CYP-1 could inhibit the overproduction of pro-inflammatory cytokines (such as TNF-α and IL-1β) in LPS-induced RAW 264.7 cells and DSS-induced colitis mice. Oral administration of CYP-1 dramatically alleviated colonic pathological damage, suppressed the activation of colonic inflammatory signaling pathways (such as NF-κB and NLRP3 inflammasome), recovered the mRNA expression of junctional proteins (such as ZO-1, claudin-1, occludin, and connexin-43), and modulated the gut microbiota by decreasing the abundances of Alistipes, Helicobacter, and an unidentified Enterobacteriaceae, in DSS-induced colitis mice. Overall, the present study elucidated that a new polysaccharide structure CYP-1 from Chinese yam and its therapeutic potential as a prebiotic for the prevention of inflammatory bowel disease.
|
Authors | Pan Li, Nan Xiao, Liping Zeng, Jie Xiao, Jianzhao Huang, Yanan Xu, Yanlan Chen, Yunhong Ren, Bing Du |
Journal | Carbohydrate polymers
(Carbohydr Polym)
Vol. 250
Pg. 116958
(Dec 15 2020)
ISSN: 1879-1344 [Electronic] England |
PMID | 33049862
(Publication Type: Journal Article)
|
Copyright | Copyright © 2020 Elsevier Ltd. All rights reserved. |
Chemical References |
- Inflammasomes
- Polysaccharides
- mannoglucan
- Dextran Sulfate
|
Topics |
- Animals
- Colitis
(chemically induced, drug therapy)
- Dextran Sulfate
(toxicity)
- Dioscorea
(chemistry)
- Dysbiosis
(drug therapy, microbiology)
- Gastrointestinal Microbiome
- Inflammasomes
(drug effects)
- Inflammation
(drug therapy, etiology, pathology)
- Male
- Mice
- Mice, Inbred C57BL
- Polysaccharides
(chemistry, isolation & purification, pharmacology)
- Signal Transduction
|